Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,727 | 18,555 | 8,505 | 12,128 | 11,843 |
| Depreciation Amortization | 6,882 | 2,956 | 2,773 | 2,833 | 3,147 |
| Income taxes - deferred | -396 | -326 | -658 | -484 | -901 |
| Accounts receivable | -738 | -496 | -242 | 295 | 137 |
| Accounts payable and accrued liabilities | 114 | 52 | 9 | 286 | -265 |
| Other Working Capital | -4,323 | -4,042 | 6,138 | -46 | -366 |
| Other Operating Activity | 790 | 135 | 383 | -484 | 206 |
| Operating Cash Flow | $17,056 | $16,834 | $16,908 | $14,528 | $13,801 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -540 | 460 | -1,597 | -3,293 | -176 |
| Sale Of Investment | N/A | 74 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -21,000 | N/A | N/A | -9 | -70 |
| Other Investing Activity | -21,000 | 0 | 0 | -9 | -70 |
| Investing Cash Flow | $-21,540 | $534 | $-1,597 | $-3,302 | $-246 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -4,777 |
| Common Stock Issued | 283 | 454 | 302 | 376 | 343 |
| Common Stock Repurchased | -398 | -1,205 | N/A | -2,850 | -683 |
| Dividend Paid | -4,112 | -4,026 | -2,955 | -3,916 | -3,846 |
| Other Financing Activity | 0 | 0 | 0 | 50 | 72 |
| Financing Cash Flow | $-4,227 | $-4,777 | $-2,653 | $-6,340 | $-8,891 |
| Exchange Rate Effect | 386 | -1,354 | 921 | -1,868 | -660 |
| Beginning Cash Position | 51,112 | 39,875 | 26,296 | 23,278 | 19,274 |
| End Cash Position | 42,787 | 51,112 | 39,875 | 26,296 | 23,278 |
| Net Cash Flow | $-8,325 | $11,237 | $13,579 | $3,018 | $4,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,056 | 16,834 | 16,908 | 14,528 | 13,801 |
| Capital Expenditure | -540 | -402 | -1,597 | -3,293 | -176 |
| Free Cash Flow | 16,516 | 16,432 | 15,311 | 11,235 | 13,625 |